the Chief sanitary doctor of Russia Anna Popova said that the first to vaccinate against coronavirus are people from risk groups, however, the authorities are working to vaccines enough for all. In groups of risk are elderly and suffering from chronic diseases the Russians.
risk Groups get vaccinated against coronavirus in the first place, if doses of vaccines against SARS-CoV-2 not to be missed at all. In an interview with RIA “Novosti” said the head of Rospotrebnadzor Anna Popova.
“If I get the chance, and today she worked out at the state level, then we will be able to develop a vaccine for the greater part of the population“, — said the chief sanitary doctor of Russia.
risk Groups include the elderly over 65 years of age and carriers of chronic diseases such as diabetes, kidney disease and various forms of cancer. Particular danger coronavirus is for those whose immune system is so weakened by the disease. Among other things this fall, and people with asthma and other chronic respiratory diseases. Count on a vaccine in the first place can, apparently, and people with hypertension and cardiovascular diseases.
However, a few days ago the head of the Department of Microbiology of latent infections nits of epidemiology and Microbiology named Gamalei Viktor Zuev said that vaccination will affect primarily those who are at risk. That is, doctors and workers in contact with a large number of people:
According to the virologist, in the future, vaccinations against COVID-19 will be put in the same way as flu. The outbreak of the coronavirus will occur twice a year, he added — in late autumn and early spring when low level immunity due climate change.
we will Add that earlier the Minister of health of the Russian Federation Mikhail Murashko said that the first results of tests of a vaccine against coronavirus should appear at the end of July. Proceeding according to schedule pre-clinical tests of the drug on a vaccine to work, several leading Russian companies.
Head nits of epidemiology and Microbiology them. Gamalei Alexander Gintsburg four days ago reported that a vaccine against a new type of coronavirus tested on a small group of volunteers. He also noted that the appearance of the drug you can expect by the end of summer. In this sample, according to Gunzburg, have shown high efficiency during experiments on laboratory rodents. The expert stressed that vaccination to all Russians from do not work even after registration and the start of production of the drug.
on 21 may, the head of the laboratory of nits them. Gamalei, Ministry of health of the Russian Federation Vladimir Gushchin reported that the pilot ts of the Russian vaccines against coronavirus infection, designed to protect doctors and are most vulnerable to the infection groups of population, will be ready by the fall.
According to him, Russian design and vector platform for testing are at a high level:
He added that currently also tested the two drugs against the coronavirus that causes favipiravir and ramdevpir, which was originally designed to fight the influenza virus, hepatitis C and Ebola.
Finally, it is worth quoting the opinion of the academician of RAS, honored scientist of the Russian Federation Sergey Kolesnikov. He said the “parliamentary newspaper”, that “non-traditional” or “military”, the way of vaccinations will start doing this year — in the fall or winter. There is a special principle of registration of medications in an emergency situation.
“it is possible that we can go on military type given the high mortality and susceptibility of the population. In this case, will instill not all the population, and the “threatening” population, those who work in the centers coronavirus infection, as well as people who have risks of severe disease,” — said Kolesnikov.
